EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a monoclonal antibody-based competitive ELISA as a surrogate assay for detecting neutralizing anti-interferon gamma autoantibodies in adult-onset immunodeficiency

Kanokporn Sornsuwan, Kanyarat Thongheang, Ekkarat Wongsawat, Chatchai Tayapiwatana, Umpa Yasamut iD

PLOS One · 13.03.2026 · 21 (3) · e0344451

DOI: 10.1371/journal.pone.0344451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.03.2026. Verfasst von Kanokporn Sornsuwan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Interferon-gamma, Autoantibodies, Antibodies, Neutralizing, Antibodies, Monoclonal. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutralizing anti-interferon gamma autoantibodies (nAIGAs) play a pivotal role in the pathogenesis of adult-onset immunodeficiency (AOID), predisposing affected individuals to severe opportunistic infections. Current detection of nAIGAs relies on cell-based assays requiring flow cytometric analysis, which limits routine clinical settings. Notably, nAIGAs recognizing the B27 epitope of interferon gamma (IFN-γ) exhibit strong neutralizing activity, underscoring the need for practical, epitope-specific detection methods for routine diagnostic. This study aimed to develop and validate a competitive enzyme-linked immunosorbent assay (cELISA) as a surrogate assay for detecting B27 epitope-targeting nAIGAs in plasma samples from patients with AOID. Plasma samples from patients with AOID (n = 40) and healthy controls (n = 40) were initially screened for AIGAs using an indirect ELISA. Neutralizing activity was confirmed using a cell-based assay measuring MHC class II expression on IFN-γ-stimulated THP-1 cells. The cELISA was subsequently developed and optimized to detect nAIGAs specific to the B27 epitope. ROC curve analysis was performed to assess the diagnostic performance of the assay. All AOID samples with detectable levels of AIGAs showed percentage inhibition above the cut-off in the cell-based assay, confirming the neutralizing activity of AIGAs. The developed cELISA detected nAIGAs in 36 of 40 AOID samples, with no false-positive results observed among healthy controls. ROC curve analysis indicated excellent diagnostic performance, yielding an area under curves (AUC) of 0.9684. Taken together, our findings indicate that the developed cELISA serves as a surrogate assay for detecting nAIGAs targeting the B27 epitope of IFN-γ. This assay represents a practical and scalable tool for AOID screening and may facilitate broader applications in clinical diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon-gammaAutoantibodiesAntibodies, NeutralizingAntibodies, MonoclonalImmunologic Deficiency SyndromesHumansEnzyme-Linked Immunosorbent AssayAdultFemaleMaleROC CurveEpitopes

Substanzen

Interferon-gammaAutoantibodiesAntibodies, NeutralizingAntibodies, MonoclonalEpitopes

Autor:innen und Institutionen

  • Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand.
  • Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Center of Innovative Immunodiagnostic Development, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.

ORCID-Profile: Umpa Yasamut

Förderung

  • Faculty of Associated Medical Sciences, Chiang Mai University
  • Chiang Mai University

Zitieren

APA

Sornsuwan, K., Thongheang, K., Wongsawat, E., Tayapiwatana, C., & Yasamut, U. (2026). Development of a monoclonal antibody-based competitive ELISA as a surrogate assay for detecting neutralizing anti-interferon gamma autoantibodies in adult-onset immunodeficiency. PLOS One, 21(3), e0344451. https://doi.org/10.1371/journal.pone.0344451

Vancouver

Sornsuwan K, Thongheang K, Wongsawat E, Tayapiwatana C, Yasamut U. Development of a monoclonal antibody-based competitive ELISA as a surrogate assay for detecting neutralizing anti-interferon gamma autoantibodies in adult-onset immunodeficiency. PLOS One. 2026;21(3):e0344451. doi:10.1371/journal.pone.0344451

BibTeX
@article{Sornsuwan2026,
  author = {Sornsuwan, Kanokporn and Thongheang, Kanyarat and Wongsawat, Ekkarat and Tayapiwatana, Chatchai and Yasamut, Umpa},
  title = {Development of a monoclonal antibody-based competitive ELISA as a surrogate assay for detecting neutralizing anti-interferon gamma autoantibodies in adult-onset immunodeficiency},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0344451},
  doi = {10.1371/journal.pone.0344451}
}
Kostenlos starten →